Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study - Iurlo, A.; Cattaneo, D.; Consonni, D.; Castagnetti, F.; Miggiano, M. C.; Binotto, G.; Bonifacio, M.; Rege-Cambrin, G.; Tiribelli, M.; Lunghi, F.; Gozzini, A.; Pregno, P.; et al. (Frontiers in pharmacology, 2023)
Keywords: chronic myeloid leukemia; low dose; outcome; Pharmacology; resistance; treatment-free remission; tyrosine kinase inhibitors; tyrosine kinase inhibitors; chronic myeloid leukemia; low dose; outcome; resistance; treatment-free remission